Brossart P - Search Results

1

The use of dendritic cells in cancer immunotherapy.

Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Among authors: brossart p. Crit Rev Oncol Hematol. 2008 Mar;65(3):191-9. doi: 10.1016/j.critrevonc.2007.10.002. Epub 2007 Dec 4. Crit Rev Oncol Hematol. 2008. PMID: 18055210 Review.

2

Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.

Brossart P, Grünebach F, Stuhler G, Reichardt VL, Möhle R, Kanz L, Brugger W. Brossart P, et al. Blood. 1998 Dec 1;92(11):4238-47. Blood. 1998. PMID: 9834229 Free article.

3

Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters.

Stuhler G, Zobywalski A, Grünebach F, Brossart P, Reichardt VL, Barth H, Stevanovic S, Brugger W, Kanz L, Schlossman SF. Stuhler G, et al. Among authors: brossart p. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1532-5. doi: 10.1073/pnas.96.4.1532. Proc Natl Acad Sci U S A. 1999. PMID: 9990058 Free PMC article.

4

Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation.

Brugger W, Brossart P, Scheding S, Stuhler G, Heinrich K, Reichardt V, Grünebach F, Bühring HJ, Kanz L. Brugger W, et al. Among authors: brossart p. Ann N Y Acad Sci. 1999 Apr 30;872:363-71. doi: 10.1111/j.1749-6632.1999.tb08480.x. Ann N Y Acad Sci. 1999. PMID: 10372138 Review.

5

Induction of minor histocompatiblity antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation.

Brossart P, Spahlinger B, Grünebach F, Stuhler G, Reichardt VL, Kanz L, Brugger. Brossart P, et al. Blood. 1999 Dec 15;94(12):4374-6. Blood. 1999. PMID: 10636695 Free article. No abstract available.

6

Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.

Brossart P, Zobywalski A, Grünebach F, Behnke L, Stuhler G, Reichardt VL, Kanz L, Brugger W. Brossart P, et al. Cancer Res. 2000 Aug 15;60(16):4485-92. Cancer Res. 2000. PMID: 10969796

7

Dendritic cell-based vaccines in patients with hematological malignancies.

Brugger W, Schneider A, Schammann T, Dill P, Grünebach F, Bühring HJ, Kanz L, Brossart P. Brugger W, et al. Among authors: brossart p. Ann N Y Acad Sci. 2001 Jun;938:359-62; discussion 362-3. doi: 10.1111/j.1749-6632.2001.tb03603.x. Ann N Y Acad Sci. 2001. PMID: 11458523

8

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.

Brossart P, Schneider A, Dill P, Schammann T, Grünebach F, Wirths S, Kanz L, Bühring HJ, Brugger W. Brossart P, et al. Cancer Res. 2001 Sep 15;61(18):6846-50. Cancer Res. 2001. PMID: 11559560

9

New perspectives in dendritic cell-based cancer immunotherapy.

Nencioni A, Brossart P. Nencioni A, et al. Among authors: brossart p. BioDrugs. 2001;15(10):667-79. doi: 10.2165/00063030-200115100-00004. BioDrugs. 2001. PMID: 11604048 Review.

10

Dendritic cells in cancer vaccines.

Brossart P, Wirths S, Brugger W, Kanz L. Brossart P, et al. Exp Hematol. 2001 Nov;29(11):1247-55. doi: 10.1016/s0301-472x(01)00730-5. Exp Hematol. 2001. PMID: 11698120 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters